FDA: Class I recall of SentreHeart’s FindrWIRZ Guidewire System
Editor's Note
The Food and Drug Administration (FDA) on November 22 categorized the recall by SentreHeart (Redwood City, California) of its FindrWIRZ Guidewire System as Class I, the most serious.
The recall was initiated because the PTFE coating may separate from the packaging and potentially cause serious injuries to patients. The system is used during minimally invasive cerebrovascular, cardiovascular, and peripheral vascular procedures.
The recall affects Lot Numbers 01160568, 02160586, and 07160639 -150, which were distributed between June 1 and September 26, 2016, and manufactured between January 4 and July 22, 2016.
Posted 11/22/2016] AUDIENCE: Surgery, Cardiology, Neurology, Risk Manager ISSUE: SentreHeart is recalling the FindrWIRZ Guidewire System because the PTFE coating may separate (e.g., peel, flake, shed, delaminate, slough off) from the packaging and potentially cause serious injuries to patients. Coating separation may be caused by issues with the device design or manufacturing processes.
Read More >>
Free Daily News
- HCA Healthcare reports solid first-quarter financials
- Per-person healthcare spending grows nearly 19% in 5 years
- OR Manager Conference: Lowest rates expire in one week
- Hospitals boost cybersecurity budgets, staff
- Kentucky passes first-ever state law decriminalizing medical mistakes
- Kaiser Permanente data breach affects 13.4 million
- Study explores link between diverticulitis and colorectal cancer
- State lawmakers target rising healthcare costs via legislation on hospital facility fees
- FDA medical device Class 1 recalls trend upward
- Data cast doubt on recommendation to delay weight-loss meds prior to surgery